Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Comparing Copy Number Variations and SNPs02:26

Comparing Copy Number Variations and SNPs

17.3K
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
17.3K
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

12.5K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
12.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Toward a Better Paradigm for Head and Neck Cancer Treatment Applying AI (HNC-TACTIC): Protocol for an International Cohort Study of Electronic Health Records.

JMIR research protocols·2026
Same author

Emergency integrative supportive care program for frail patients with advanced pancreatic cancer: A prospective GERCOR ARCAD study.

medRxiv : the preprint server for health sciences·2026
Same author

A Clinically Integrated Pediatric Patient-Derived Xenograft Program Enables Evaluation of Cohort and Patient-Specific Biology and Therapeutic Strategies.

Cancer research·2026
Same author

Tumor microbial burden drives immune responses through regulation of Interferon signaling.

Cancer discovery·2026
Same author

Molecular and Clinical Determinants of Targeted Therapy Treatment in Biliary Tract Cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

The Genomic Landscape of MYC, MYCL, and MYCN Amplified Solid Tumors.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026

Related Experiment Video

Updated: Jun 7, 2025

Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing
11:02

Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing

Published on: October 18, 2013

19.4K

Analysis of Shared Variants between Cancer Biospecimens.

Michael B Foote1, James Robert White1,2, Walid K Chatila3

  • 1Division of Solid Tumor Oncology, Memorial Sloan Kettering, New York, New York.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|November 19, 2024
PubMed
Summary

A new mutational profile similarity (MPS) score helps determine if cancer samples from one patient are related or coincidental. This tool aids in distinguishing single versus multiple cancers and can predict diagnostic changes.

More Related Videos

Comparative Lesions Analysis Through a Targeted Sequencing Approach
08:16

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

6.7K
Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
13:24

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

11.8K

Related Experiment Videos

Last Updated: Jun 7, 2025

Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing
11:02

Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing

Published on: October 18, 2013

19.4K
Comparative Lesions Analysis Through a Targeted Sequencing Approach
08:16

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

6.7K
Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
13:24

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

11.8K

Area of Science:

  • Genomics
  • Cancer Research
  • Bioinformatics

Background:

  • Integrating mutational data from multiple patient biospecimens is crucial for tracking cancer evolution.
  • A lack of a standardized framework exists to differentiate shared variants due to common identity versus coincidence.

Purpose of the Study:

  • To develop a computational framework for assessing the molecular relationship between biospecimens from the same individual.
  • To establish confidence estimates for whether two tumors share a unique, related molecular profile.

Main Methods:

  • Utilized 8,000 patient tumors from The Cancer Genome Atlas across 33 cancer types.
  • Developed a mutational profile similarity (MPS) score using a large background database of mutation co-occurrence rates.
  • Applied the MPS algorithm to analyze tumor profiles from repeat biopsies, multiple cancers in single patients, and plasma-solid tumor pairs.

Main Results:

  • Nucleotide-specific variants are shared in 1.3% of cancer-type agnostic and 10-13% of cancer-type specific unrelated tumors.
  • The MPS method successfully contextualized shared variants to distinguish single from multiple distinct cancers.
  • In cases with discordant clinicopathologic and molecular findings, MPS anticipated future diagnosis changes in 28% of instances.

Conclusions:

  • A novel shared variant framework, the MPS score, can clarify the molecular relationship between biospecimens.
  • This approach provides valuable insights with minimal input, aiding in cancer diagnosis and evolution tracking.